Kimberly-Clark to buy Kenvue in $48.7bn deal
By Michele Maatouk
Date: Monday 03 Nov 2025
(Sharecast News) - Kimberly-Clark said on Monday that it has agreed to buy consumer health firm Kenvue in a $48.7bn cash and stock deal.
Under the terms of the agreement, Kenvue shareholders will receive $3.50 per share in cash and 0.14625 Kimberly-Clark shares for each of their shares.
Once the deal completes, Kimberly-Clark shareholders are expected to own about 54% and Kenvue shareholders will own approximately 46% of the combined company on a fully diluted basis.
"This transaction brings together two iconic American companies to create a combined portfolio of complementary products, including 10 billion-dollar brands, that touch nearly half the global population through every stage of life," Kimberly-Clark said.
Chairman and chief executive Mike Hsu said: "We are excited to bring together two iconic companies to create a global health and wellness leader.
"Kenvue is uniquely positioned at the intersection of CPG and healthcare, with exceptional talent and a differentiated brand offering serving attractive consumer health categories. With a shared commitment to developing science and technology to provide extraordinary care, we will serve billions of consumers across every stage of life."
It was estimated that the combined company would generate 2025 annual net revenues of about $32bn and approximately $7bn of adjusted EBITDA.
Kimberly-Clark is the owner of brands such as Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex and Softex, among others.
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN